Cargando…
Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA
BACKGROUND: The objective of the study was to reveal through pragmatic MCDA (EVIDEM) the contribution of a broad range of criteria to the value of the orphan drug lenvatinib for radioiodine refractory differentiated thyroid cancer (RR-DTC) in country-specific contexts. METHODS: The study was designe...
Autores principales: | Wagner, Monika, Khoury, Hanane, Bennetts, Liga, Berto, Patrizia, Ehreth, Jenifer, Badia, Xavier, Goetghebeur, Mireille |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393009/ https://www.ncbi.nlm.nih.gov/pubmed/28412971 http://dx.doi.org/10.1186/s12885-017-3258-9 |
Ejemplares similares
-
Development of a Framework Based on Reflective MCDA to Support Patient–Clinician Shared Decision-Making: The Case of the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the United States
por: Wagner, Monika, et al.
Publicado: (2017) -
Field testing of a multicriteria decision analysis (MCDA) framework for coverage of a screening test for cervical cancer in South Africa
por: Miot, Jacqui, et al.
Publicado: (2012) -
Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada
por: Tony, Michèle, et al.
Publicado: (2011) -
Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA)
por: Wahlster, Philip, et al.
Publicado: (2015) -
Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation
por: Wagner, Monika, et al.
Publicado: (2015)